StonvexLoading…
StonvexStonvexStonvexCore line items from BXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.95B | $2.95B | $3.14B | $4.45B |
Operating Income | $32.48M | $87.57M | $138.45M | $439.09M |
Net Income | $219.00K | $53.12M | $48.54M | $296.18M |
EPS (Diluted) | $0.02 | $6.19 | $5.39 | $31.51 |
Total Assets | $1.55B | $1.58B | $1.54B | $1.49B |
Total Liabilities | $931.96M | $931.28M | $903.32M | $900.01M |
Cash & Equivalents | $385.84M | $505.62M | $521.74M | $298.94M |
Free Cash Flow OCF − CapEx | $32.85M | $45.07M | $278.76M | $364.41M |
Shares Outstanding | 7.87M | 8.65M | 8.65M | 9.05M |